A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma

Cristian Capasso, Aniket Magarkar, Victor Cervera-Carascon, Manlio Fusciello, Sara Feolaf, Martin Muller, Mariangela Garofalo, Lukasz Kuryk, Siri Tahtinen, Lucio Pastore, Alex Bunker, Vincenzo Cerullo

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number1319028
JournalOncoImmunology
Volume6
Issue number9
Number of pages14
ISSN2162-402X
DOIs
Publication statusPublished - 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Cancer vaccine
  • heteroclitic peptides
  • immunotherapy
  • in silico
  • prediction servers
  • tumor antigens
  • TUMOR-REACTIVE CTL
  • T-CELL EPITOPES
  • CROSS-REACTIVITY
  • IMMUNE-RESPONSES
  • PEPTIDE LIGANDS
  • VACCINE
  • CANCER
  • RECOGNITION
  • IMMUNOGENICITY
  • MELAN-A/MART-1
  • 3122 Cancers

Cite this

Capasso, Cristian ; Magarkar, Aniket ; Cervera-Carascon, Victor ; Fusciello, Manlio ; Feolaf, Sara ; Muller, Martin ; Garofalo, Mariangela ; Kuryk, Lukasz ; Tahtinen, Siri ; Pastore, Lucio ; Bunker, Alex ; Cerullo, Vincenzo. / A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma. In: OncoImmunology. 2017 ; Vol. 6, No. 9.
@article{2ea753819e7f4e34a718b4f322c300db,
title = "A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma",
keywords = "Cancer vaccine, heteroclitic peptides, immunotherapy, in silico, prediction servers, tumor antigens, TUMOR-REACTIVE CTL, T-CELL EPITOPES, CROSS-REACTIVITY, IMMUNE-RESPONSES, PEPTIDE LIGANDS, VACCINE, CANCER, RECOGNITION, IMMUNOGENICITY, MELAN-A/MART-1, 3122 Cancers",
author = "Cristian Capasso and Aniket Magarkar and Victor Cervera-Carascon and Manlio Fusciello and Sara Feolaf and Martin Muller and Mariangela Garofalo and Lukasz Kuryk and Siri Tahtinen and Lucio Pastore and Alex Bunker and Vincenzo Cerullo",
year = "2017",
doi = "10.1080/2162402X.2017.1319028",
language = "English",
volume = "6",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "TAYLOR & FRANCIS INC",
number = "9",

}

Capasso, C, Magarkar, A, Cervera-Carascon, V, Fusciello, M, Feolaf, S, Muller, M, Garofalo, M, Kuryk, L, Tahtinen, S, Pastore, L, Bunker, A & Cerullo, V 2017, 'A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma' OncoImmunology, vol. 6, no. 9, 1319028. https://doi.org/10.1080/2162402X.2017.1319028

A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma. / Capasso, Cristian; Magarkar, Aniket; Cervera-Carascon, Victor; Fusciello, Manlio; Feolaf, Sara; Muller, Martin; Garofalo, Mariangela; Kuryk, Lukasz; Tahtinen, Siri; Pastore, Lucio; Bunker, Alex; Cerullo, Vincenzo.

In: OncoImmunology, Vol. 6, No. 9, 1319028, 2017.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma

AU - Capasso, Cristian

AU - Magarkar, Aniket

AU - Cervera-Carascon, Victor

AU - Fusciello, Manlio

AU - Feolaf, Sara

AU - Muller, Martin

AU - Garofalo, Mariangela

AU - Kuryk, Lukasz

AU - Tahtinen, Siri

AU - Pastore, Lucio

AU - Bunker, Alex

AU - Cerullo, Vincenzo

PY - 2017

Y1 - 2017

KW - Cancer vaccine

KW - heteroclitic peptides

KW - immunotherapy

KW - in silico

KW - prediction servers

KW - tumor antigens

KW - TUMOR-REACTIVE CTL

KW - T-CELL EPITOPES

KW - CROSS-REACTIVITY

KW - IMMUNE-RESPONSES

KW - PEPTIDE LIGANDS

KW - VACCINE

KW - CANCER

KW - RECOGNITION

KW - IMMUNOGENICITY

KW - MELAN-A/MART-1

KW - 3122 Cancers

U2 - 10.1080/2162402X.2017.1319028

DO - 10.1080/2162402X.2017.1319028

M3 - Article

VL - 6

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 9

M1 - 1319028

ER -